21-hydroxylase deficiency classification: Difference between revisions
Jump to navigation
Jump to search
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
21-hydroxylase deficiency may be classified into two subtypes based on severity and time of onset: classic and non-classic forms. Classic form includes two subtypes salt-wasting and non-salt wasting 21-hydroxylase deficiency. | 21-hydroxylase deficiency may be classified into two subtypes based on severity and time of onset: classic and non-classic forms. Classic form includes two subtypes salt-wasting and non-salt wasting 21-hydroxylase deficiency. | ||
== | ==Classification== | ||
21- | 21-hydroxylase deficiency my be classified by clinical manifestations in to two forms: | ||
*Classical form, most severe form of 21-hydroxylase deficiency, presents during the neonatal period and early infancy. The | *Classical form, most severe form of 21-hydroxylase deficiency, presents during the [[neonatal]] period and early infancy. The classic form can be classified in to two subtypes based on [[aldosterone]] status: | ||
** | **Classic salt wasting, [[aldosterone]] deficient. | ||
** | **Classic non-salt wasting, normal [[aldosterone]]. | ||
*Non- | *Non-classic form or late-onset 21-hydroxylase deficiency, presents later during the [[adolescence]] period.<ref name="pmid10857554">{{cite journal |vauthors=White PC, Speiser PW |title=Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |journal=Endocr. Rev. |volume=21 |issue=3 |pages=245–91 |year=2000 |pmid=10857554 |doi=10.1210/edrv.21.3.0398 |url=}}</ref><ref name="pmid20823466">{{cite journal |vauthors=Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC |title=Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline |journal=J. Clin. Endocrinol. Metab. |volume=95 |issue=9 |pages=4133–60 |year=2010 |pmid=20823466 |pmc=2936060 |doi=10.1210/jc.2009-2631 |url=}}</ref> | ||
== References == | == References == | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 17:59, 31 July 2017
|
21-hydroxylase deficiency Microchapters |
|
Differentiating 21-Hydroxylase Deficiency from other Diseases |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
21-hydroxylase deficiency classification On the Web |
|
American Roentgen Ray Society Images of 21-hydroxylase deficiency classification |
|
Risk calculators and risk factors for 21-hydroxylase deficiency classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Mehrian Jafarizade, M.D [2]
Overview
21-hydroxylase deficiency may be classified into two subtypes based on severity and time of onset: classic and non-classic forms. Classic form includes two subtypes salt-wasting and non-salt wasting 21-hydroxylase deficiency.
Classification
21-hydroxylase deficiency my be classified by clinical manifestations in to two forms:
- Classical form, most severe form of 21-hydroxylase deficiency, presents during the neonatal period and early infancy. The classic form can be classified in to two subtypes based on aldosterone status:
- Classic salt wasting, aldosterone deficient.
- Classic non-salt wasting, normal aldosterone.
- Non-classic form or late-onset 21-hydroxylase deficiency, presents later during the adolescence period.[1][2]
References
- ↑ White PC, Speiser PW (2000). "Congenital adrenal hyperplasia due to 21-hydroxylase deficiency". Endocr. Rev. 21 (3): 245–91. doi:10.1210/edrv.21.3.0398. PMID 10857554.
- ↑ Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC (2010). "Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline". J. Clin. Endocrinol. Metab. 95 (9): 4133–60. doi:10.1210/jc.2009-2631. PMC 2936060. PMID 20823466.